ADVANCE
Advance Agrolife Limited
Advance Agrolife Limited (ADVANCE) financial statements and selected valuation metrics through 30 June 2026.
Commodities›Chemicals›Fertilizers & Agrochemicals›Pesticides & Agrochemicals
advanceagrolife.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Advance Agrolife (AAL) makes technical and formulated agrochemicals, including herbicides, insecticides, fungicides and plant growth regulators, mostly for large corporate customers, from plants near Jaipur in Rajasthan.
Company snapshot
17thBy market cap
Ranked among 23 companies in Pesticides & Agrochemicals.
What we see
- ✗Over the last three years operations used more cash than they brought in, despite an operating profit — the business is not yet turning its profit into cash.
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Sales | 169 Cr | 213 Cr | 133 Cr | 124 Cr | 330 Cr |
| Operating expenses (approx.) | 152 Cr | 187 Cr | 125 Cr | 111 Cr | 295 Cr |
| EBITDA | 17 Cr | 26 Cr | 7 Cr | 13 Cr | 35 Cr |
| OPM % | 10.1% | 12.1% | 5.5% | 10.8% | 10.6% |
| Other income | 0.14 Cr | 0.23 Cr | 1 Cr | 2 Cr | 0.22 Cr |
| Interest | 2 Cr | 2 Cr | 1 Cr | 2 Cr | 2 Cr |
| Depreciation | 2 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr |
| Profit before tax | 13 Cr | 21 Cr | 4 Cr | 10 Cr | 30 Cr |
| Tax % | 29.2% | 25.1% | 29.7% | 25.4% | 25.5% |
| Net profit | 9 Cr | 16 Cr | 3 Cr | 7 Cr | 23 Cr |
| EPS (₹) | ₹1.99 | ₹3.53 | ₹0.47 | ₹1.05 | ₹3.50 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Sales | 398 Cr | 456 Cr | 502 Cr | 638 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 373 Cr | 417 Cr | 455 Cr | 574 Cr | Sign in free for the trailing twelve months |
| EBITDA | 25 Cr | 39 Cr | 48 Cr | 64 Cr | Sign in free for the trailing twelve months |
| OPM % | 6.3% | 8.5% | 9.5% | 10.0% | Sign in free for the trailing twelve months |
| Other income | 0.17 Cr | 1 Cr | 0.62 Cr | 4 Cr | Sign in free for the trailing twelve months |
| Interest | 3 Cr | 4 Cr | 5 Cr | 9 Cr | Sign in free for the trailing twelve months |
| Depreciation | 2 Cr | 3 Cr | 8 Cr | 11 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 20 Cr | 33 Cr | 35 Cr | 48 Cr | Sign in free for the trailing twelve months |
| Tax % | 26.1% | 25.7% | 27.2% | 26.7% | Sign in free for the trailing twelve months |
| Net profit | 15 Cr | 25 Cr | 26 Cr | 35 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹3.30 | ₹5.50 | ₹5.70 | ₹6.50 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | 0.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity capital | 5 Cr | 5 Cr | 45 Cr | 64 Cr |
| Reserves | 46 Cr | 71 Cr | 56 Cr | 246 Cr |
| Borrowings | 25 Cr | 45 Cr | 79 Cr | 96 Cr |
| Other liabilities | 104 Cr | 139 Cr | 171 Cr | 219 Cr |
| Total liabilities | 179 Cr | 260 Cr | 351 Cr | 625 Cr |
| Fixed assets (net) | 23 Cr | 40 Cr | 65 Cr | 81 Cr |
| CWIP | 0.15 Cr | 9 Cr | 11 Cr | 22 Cr |
| Investments | — | — | — | 0 Cr |
| Inventories | 39 Cr | 49 Cr | 88 Cr | 205 Cr |
| Trade receivables | 104 Cr | 143 Cr | 163 Cr | 196 Cr |
| Cash & bank | 0.07 Cr | 0.46 Cr | 0.58 Cr | 5 Cr |
| Other assets | 13 Cr | 17 Cr | 25 Cr | 115 Cr |
| Total assets | 179 Cr | 260 Cr | 351 Cr | 625 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Cash from operating activity | 6 Cr | 15 Cr | 6 Cr | -70 Cr |
| Cash from investing | -8 Cr | -31 Cr | -34 Cr | -108 Cr |
| Cash from financing | 1 Cr | 17 Cr | 28 Cr | 183 Cr |
| Net cash flow | -0.40 Cr | 0.39 Cr | 0.12 Cr | 5 Cr |
| Free cash flow (OCF − Capex) | -2 Cr | -15 Cr | -28 Cr | -109 Cr |
Ratios
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| ROCE % | 30.0% | 30.5% | 22.6% | 14.0% |
| ROE % | 29.4% | 32.9% | 25.4% | 11.4% |
| Debtor days | 96 | 115 | 118 | 112 |
| Inventory days | 43 | 49 | 84 | 147 |
| Days payable | 103 | 128 | 152 | 150 |
| Cash conversion cycle | 35 | 36 | 50 | 109 |
| OCF / EBITDA % | 24.9% | 38.2% | 12.0% | -110.0% |
| OCF / EBITDA % (3 years) | — | — | 24.0% | -32.9% |
| Debt / equity | 0.50 | 0.60 | 0.79 | 0.31 |
| Current ratio | 1.27 | 1.22 | 1.16 | 1.67 |
| Net debt / EBITDA | 1.00 | 1.15 | 1.65 | 1.42 |